KVP Capital Advisors »

Nektar Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 27k 42.28

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
Emerald Advisers
22NW
Dr. Jeffrey R. Jay, M.D.
UBS Group
PRIMECAP Management Company
Armistice Capital

View all funds holding Nektar Therapeutics